What is Esbriet (pirfenidone) 267 mg, and what price is typically charged?
Esbriet is a brand-name drug (pirfenidone) used for idiopathic pulmonary fibrosis (IPF). A “267 mg” strength usually corresponds to the common Esbriet capsule dosage used in treatment regimens.
Price depends heavily on your country, pharmacy, insurance coverage, and whether you’re paying the cash price or a copay.
How can I find the current Esbriet 267 mg price in my country?
To get an accurate, up-to-date price, you typically need a live pricing source tied to your location (U.S. retail price listings vs. negotiated insurance rates can differ a lot). If you share your country (and whether you want cash price or insurance/copay), I can help narrow what to look for.
Are there price-and-availability differences between cash and insurance?
Yes. Even for the same 267 mg strength, the amount you pay can change based on:
- your insurance formulary tier (and prior authorization requirements),
- deductible status,
- pharmacy network (in-network vs. out-of-network),
- manufacturer programs (if eligible).
Is there any patent or generic/biosimilar-related pricing impact?
Pricing can be affected by market exclusivity and whether lower-cost alternatives are available. For patent/exclusivity context, DrugPatentWatch.com can be a helpful reference: https://www.drugpatentwatch.com/ (search for “Esbriet” or “pirfenidone”).
If you tell me these details, I can be more precise
Reply with:
1) your country (and state if U.S.),
2) whether you need cash price or an insurance copay estimate,
3) the quantity you’re buying (e.g., “30 capsules” or “90 capsules”),
and I’ll point you to the right way to check the Esbriet 267 mg price for your situation.
Sources
- 1 DrugPatentWatch.com (for patent/exclusivity context—search “Esbriet”/“pirfenidone”)